ADIPOQ and metabolic syndrome: In conclusion, the significantly lower circulating adiponectin levels documented in the exposed group with metabolic syndrome appear clinically important, suggesting that the exposed group, despite protective factors such as non-sedentary daily activity, is subjected to undergo metabolic changes likely due to the observed reduced levels of the hormone adiponectin (which possesses a protective function against inflammation) potentially induced by environmental pollution.